Severe neonatal hyperbilirubinemia and adverse short-term consequences in Baghdad, Iraq

Neonatology

Volumn 100, Issue 1, 2011, Pages 57-63

  Hameed, Numan Nafie ^a,c   Na'ma, Alaa Muhamed ^a   Vilms, Rohan ^b   Bhutani, Vinod K ^b  

^a UNIVERSITY OF BAGHDAD   (Iraq)

^b STANFORD UNIVERSITY   (United States)

^c BAGHDAD TEACHING HOSPITAL   (Iraq)

Author keywords

Acute bilirubin encephalopathy; Kernicterus; Newborn jaundice; Severe neonatal hyperbilirubinemia

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; DISEASE SEVERITY; EXCHANGE BLOOD TRANSFUSION; HOME DELIVERY; HOSPITAL ADMISSION; HUMAN; HYPERBILIRUBINEMIA; INFANT; IRAQ; KERNICTERUS; MAJOR CLINICAL STUDY; NEWBORN JAUNDICE; NEWBORN MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SEPSIS; SURVIVAL;

AGE FACTORS; EXCHANGE TRANSFUSION, WHOLE BLOOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT MORTALITY; INFANT, NEWBORN; IRAQ; JAUNDICE, NEONATAL; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 78650865648     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000321990     Document Type: Article

References (35)

1. American Academy of Pediatrics Clinical Practice Guideline: Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004; 114: 297-316.
2. Bhutani VK, Johnson LH, Maisels MJ, Newman TB, Phibbs C, Stark AR, Yeargin-All-sopp M: Kernicterus: epidemiological strategies for its prevention through systems-based approaches. J Perinatol 2004; 24: 650-662. (Pubitemid 39405878)
3. Perlstein MA: The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 1960; 7: 665-687.
4. Van Praagh R: Diagnosis of kernicterus in the neonatal period. Pediatrics 1961; 28: 870-876.
5. Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM: Clinical report from the pilot USA Kernicterus Registry (1992 to 2004). J Perinatol 2009; 29(suppl 1): S25-S45.
6. Hankø E, Lindemann R, Hansen TW: Spectrum of outcome in infants with extreme neonatal jaundice. Acta Paediatr 2001; 90: 782-785. (Pubitemid 32729210)
7. Al Otaibi SF, Blaser S, MacGregor DL: Neurological complications of kernicterus. Can J Neurol Sci 2005; 32: 11-15.
8. Bhutani VK, Johnson L: Kernicterus in the 21st century: frequently asked question. J Perinatol 2009; 29(suppl 1): 520-524.
9. Bhutani VK, Maisels MJ, Stark AR, Buonocore G: Ma nagement of jaundice and prevention of severe neonatal hyperbilirubinemia in infants >35 weeks gestation. Neonatology 2008; 94: 63-67. (Pubitemid 351896597)
10. Manning D, Todd P, Maxwell M, Platt MJ: Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the United Kingdom and Ireland. Arch Dis Child Fetal Neonatal Ed 2007; 92: F342-F346. (Pubitemid 47436215)
11. Ebbesen F, Anderson C, Verder H, et al: Extreme hyperbilirubinemia in term and nearterm infants in Denmark. Acta Pediatr 2005; 94: 59-64. (Pubitemid 40127935)
12. Sgro M, Campbell D, Shah V: Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ 2006; 175: 587-590. (Pubitemid 44439718)
13. Escobar GJ, Greene JD, Hulac P, Kincannon E, Bischoff K, Gardner MN, Armstrong MA, France EK: Rehospitalisation after birth hospitalization: patterns among infants of all gestations. Arch Dis Child 2005; 90: 125-131. (Pubitemid 40188006)
14. Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS: Readmission for neonatal jaundice in California. Pediatrics 2008; 121: e864-e869.
15. Ip S, Chung M, Kulig J, O'Brien R, Sege R, Glicken S, Maisels J, Lau J, Subcommittee on hyperbilirubinemia: an evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics 2004; 114: e130-e153.
16. Johnson LH, Bhutani VK, Brown AK: System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr 2002; 140: 396-403. (Pubitemid 34494310)
17. Bjerre JV, Petersen JR, Ebbesen F: Surveillance of extreme hyperbilirubinaemia in Denmark. A method to identify the newborn infants. Acta Paediatr 2008; 97: 1030-1034.
18. Bhutani VK, Johnson L: A proposal to prevent severe neonatal hyperbilirubinemia and kernicterus. J Perinatol 2009; 29(suppl 1): S61-S67.
19. Salas AA, Mazzi E: Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country. Acta Pediatr 2008; 97: 754-758. (Pubitemid 351652445)
20. Johnson L, Brown AK, Bhutani V: BIND - a clinical score for bilirubin induced neurologic dysfunction in newborns. Pediatrics 1999; 104: 746.
21. Shapiro SM: Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005; 25: 54-59. (Pubitemid 40207656)
22. Shapiro SM, Bhutani VK, Johnson L: Hyperbilirubinemia and kernicterus. Clin Perinatol 2006; 33: 387-410. (Pubitemid 43841897)
23. Bhutani VK, Johnson L, Sivieri EM: Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics 1999; 103: 6-14. (Pubitemid 29281921)
24. Centers for Disease Control and Prevention website. http://www.cdc.gov/ ncbddd/dd/kernichome.htm.
25. US Preventive Services Task Force: Agency for Healthcare Research and Quality. Screening of infants for hyperbilirubinemia to prevent chronic bilirubin encephalopathy: US Preventive Services Task Force recommendation statement. Pediatrics 2009; 124: 1172-1177.
26. Newman TB, Liljestrand P, Escobar GJ: Infants with bilirubin levels of 30 mg/dl or more in a large managed care organization. Pediatrics 2003; 111: 1303-1311. (Pubitemid 36682263)
27. Ahlfors CE, Herbsman O: Unbound bilirubin in a term newborn with kernicterus. Pediatrics 2003; 111: 1110-1112. (Pubitemid 36542630)
28. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA: Developmental follow-up of breastfed term and near-term infants with marked hyperbilirubinemia. Pediatrics 2001; 107: 1075-1080. (Pubitemid 32440614)
29. Newman TB, Liljestrand P, Jeremy RJ, Ferriero DM, Wu YW, Hudes ES, et al: Outcomes among newborns with total serum bilirubin levels of 25 mg per deciliter or more. N Engl J Med 2006; 354: 1889-1900. (Pubitemid 43872690)
30. Maisels MJ: Clinical rounds in the well-baby nursery: treating jaundiced newborns. Pediatr Ann 1995; 24: 547-552.
31. Kaplan M, Hammerman C: Glucose-6-phos-phate dehydrogenase deficiency: a potential source of severe neonatal hyperbilirubin-aemia and kernicterus. Semin Neonatol 2002; 7: 21-128.
32. Bhutani VK, Johnson L: Kernicterus in late preterm infants cared for as term healthy infants. Semin Perinatol 2006; 30: 89-97. (Pubitemid 43767137)
33. Murki S, Kumar P, Majumdar S, Marwaha N, Narang A: Risk factors for kernicterus in term babies with non-hemolytic jaundice. Indian Pediatr 2001; 38: 757-762. (Pubitemid 33606767)
34. Wennberg RP, Ahlfors CE, Bhutani VK, Johnson LH, Shapiro SM: Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns. Pediatrics 2006; 117: 474-485. (Pubitemid 46071611)
35. Hess DR: Retrospective Studies and Chart Reviews. Respir Care 2004; 49: 1171-1174.